Opinion - (2025) Volume 9, Issue 4
Received: 01-Jul-2025, Manuscript No. jchd-26-185699;
Editor assigned: 03-Jul-2025, Pre QC No. P-185699;
Reviewed: 17-Jul-2025, QC No. Q-185699;
Revised: 22-Jul-2025, Manuscript No. R-185699;
Published:
29-Jul-2025
, DOI: 10.37421/2684-6020.2024.9.256
Citation: Silva, Lucas. ”Coronary Heart Disease: Multifactorial
Risk and Management.” J Coron Heart Dis 09 (2025):255.
Copyright: © 2025 Silva L. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution
and reproduction in any medium, provided the original author and source are credited.
Coronary heart disease (CHD) is a complex and multifactorial condition intricately linked to atherosclerosis, a process characterized by the gradual accumulation of plaque within the coronary arteries. This buildup is precipitated by a constellation of key factors that disrupt vascular health. Dyslipidemia, marked by unhealthy cholesterol profiles, stands as a primary driver, alongside hypertension, which exerts damaging mechanical stress on arterial walls.
Diabetes mellitus, particularly its type 2 manifestation, represents a significant risk factor, contributing to endothelial dysfunction and accelerating atherosclerotic processes through elevated blood glucose levels. Compounding this, diabetic patients frequently exhibit a cluster of coexisting cardiovascular risk factors, such as dyslipidemia and hypertension, thereby intensifying their overall risk profile. Hypertension itself is a pervasive contributor to the development and progression of CHD. The sustained elevated pressure within the arteries leads to endothelial damage, fostering an environment conducive to atherosclerotic plaque formation and progression. Uncontrolled hypertension over extended periods markedly elevates the risk of acute events like myocardial infarction. Smoking emerges as a particularly potent and modifiable risk factor, with its constituents inflicting damage on the endothelium, promoting inflammation, and negatively impacting lipid profiles. These effects collectively fuel the atherosclerotic cascade and increase the likelihood of heart attack. Dyslipidemia, defined by aberrant levels of low-density lipoprotein (LDL) cholesterol and triglycerides alongside reduced high-density lipoprotein (HDL) cholesterol, is fundamental to CHD pathogenesis. The infiltration of LDL particles into the arterial wall initiates and propagates the formation of atherosclerotic plaques. Obesity, especially when characterized by abdominal fat accumulation, exhibits a strong correlation with increased CHD risk. This condition promotes insulin resistance, exacerbates hypertension and dyslipidemia, and cultivates a pro-inflammatory milieu, all of which contribute to the development of atherosclerosis. Physical inactivity, or a sedentary lifestyle, constitutes another major contributor to CHD. Its association with increased risks of obesity, hypertension, diabetes, and unfavorable lipid profiles creates an environment that facilitates atherosclerotic development. Genetic factors also play an influential role, predisposing individuals to CHD by affecting susceptibility to key risk factors such as blood pressure regulation, cholesterol metabolism, and the inherent propensity for atherosclerosis. While lifestyle interventions are crucial, genetic predisposition highlights the need for individualized risk assessment. Chronic inflammation is increasingly recognized as a critical underlying mechanism in atherosclerosis. Inflammatory mediators orchestrate the recruitment of immune cells to the arterial wall, thereby contributing to plaque development, progression, and instability, which can ultimately lead to plaque rupture and acute coronary events. The intricate interplay of these numerous risk factors underscores the multifactorial nature of CHD. It is rarely attributable to a single cause but rather the confluence of genetic predispositions, unhealthy lifestyle choices, and the presence of underlying medical conditions that collectively accelerate atherosclerosis and elevate the risk of cardiovascular events.Coronary heart disease (CHD) is fundamentally driven by atherosclerosis, a pathological process involving plaque buildup in the coronary arteries. This complex condition is influenced by a multitude of risk factors, including dyslipidemia, which refers to abnormal levels of cholesterol and other fats in the blood, and hypertension, characterized by persistently high blood pressure. These factors create an environment that promotes arterial damage and plaque formation.
Diabetes mellitus, particularly type 2, significantly elevates the risk of CHD. Elevated blood glucose levels in diabetic individuals contribute to endothelial dysfunction, systemic inflammation, and the acceleration of atherosclerotic processes. Furthermore, diabetic patients often present with a cluster of other cardiovascular risk factors, such as dyslipidemia and hypertension, which synergistically increase their risk. Hypertension is a pervasive and significant contributor to CHD. The elevated force of blood against arterial walls damages the endothelium, impairing its function and promoting the development and progression of atherosclerotic lesions. Chronic, uncontrolled hypertension is a major determinant of increased risk for myocardial infarction and other serious cardiovascular outcomes. Smoking stands out as a potent, yet modifiable, risk factor for CHD. The myriad toxic components within tobacco smoke inflict damage on the vascular endothelium, trigger inflammatory responses, enhance blood coagulability, and adversely affect lipid profiles. These cumulative effects significantly contribute to atherosclerosis and raise the probability of experiencing a heart attack. Dyslipidemia, a condition marked by elevated levels of low-density lipoprotein (LDL) cholesterol and triglycerides, coupled with low levels of high-density lipoprotein (HDL) cholesterol, is a cornerstone in the development of CHD. The deposition of LDL particles within the arterial wall is a critical initiating event in the cascade of plaque formation. Obesity, especially visceral or abdominal obesity, is strongly associated with an increased risk of CHD. It promotes the development of insulin resistance, contributes to hypertension and dyslipidemia, and fosters a pro-inflammatory state within the body, all of which are conducive to the pathogenesis of atherosclerosis. Physical inactivity, or a sedentary lifestyle, is a major contributor to the burden of CHD. A lack of regular physical activity is linked to an increased likelihood of developing obesity, hypertension, diabetes, and unfavorable lipid profiles, creating conditions that facilitate the development and progression of atherosclerosis. Genetic predispositions can influence an individual's susceptibility to CHD. These genetic factors can affect modifiable risk factors like blood pressure regulation, cholesterol metabolism, and the inherent tendency of arteries to develop atherosclerosis. While lifestyle changes are paramount, genetic insights are vital for personalized risk assessment. Chronic inflammation is increasingly understood as a critical underlying mechanism in the development of atherosclerosis. Inflammatory mediators are responsible for attracting immune cells to the arterial wall, contributing to plaque formation, growth, and instability. This instability can ultimately lead to plaque rupture, triggering acute coronary events. The development of CHD is typically the result of a complex interplay between multiple risk factors. It is rarely a singular cause but rather a confluence of genetic tendencies, unhealthy lifestyle choices encompassing diet and exercise, and the presence of underlying medical conditions such as hypertension and diabetes, all of which collectively accelerate atherosclerotic processes.Coronary heart disease (CHD) is primarily caused by atherosclerosis, the buildup of plaque in coronary arteries. Key contributing factors include unhealthy cholesterol levels (dyslipidemia), high blood pressure (hypertension), diabetes, smoking, obesity, a sedentary lifestyle, and genetic predisposition. Chronic inflammation plays a central role in plaque development and rupture, leading to events like myocardial infarction. The multifactorial nature of CHD necessitates comprehensive prevention and management strategies that address these interconnected risk factors. Understanding this interplay is crucial for effective cardiovascular care.
Journal of Coronary Heart Diseases received 15 citations as per Google Scholar report
